Diarrhea Infectious
13
5
5
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
The Utility and Feasibility of Accessible Diarrhea Etiology Prediction Tool (ADEPT) in an Informal Healthcare Setting
Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)
The Impact of Shigellosis and Recommended Treatment in Children
Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Hospital
Preventative Intervention for Cholera for 7 Days
Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
Study in Healthy Adults Challenged With Enterotoxigenic E. Coli, of the Safety, Tolerability and Anti-Diarrheal Activity of VENBETA6890, an Orally Administered, Human Monoclonal IgA
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
GastroIntestinal Panel in Kidney Transplant Patients
Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)
A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in Africa
The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) Algorithm